Advanced breast cancer standing committee update: Addendum consultation

NICE is currently updating its guidance on the diagnosis and treatment for people with advanced breast cancer for use in the NHS in England, Wales and Northern Ireland following new evidence on the safety and benefit of exercise for breast cancer-related lymphoedema. NICE has developed two new draft recommendations, which have been published for consultation, to directly address this issue.

Registered stakeholders for this guideline are invited to comment on the provisional recommendations in the addendum. Individuals and organisations not registered as stakeholders are not able to comment. We recommend that you register as a stakeholder or contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.

Note that the provisional recommendations presented here do not constitute the Institute's formal guidance on this topic. The recommendations are provisional and may change after consultation.

Consultation dates:12^th March – 9^th April 2014

Consultation documents

Addendum 

Comments proforma

Confidentiality agreement

The Addendum describes the evidence and views that have been considered, and sets out the provisional recommendations that have been developed.

Comments on the original guideline, as opposed to the consultation addendum, will not be considered.

Points to consider in the consultation

Addendum

• Potential inconsistencies or any disagreement with the Standing Committees interpretation of the evidence
• The practical value of the provisional recommendations.
• Do you think this guidance could be changed to better promote equality of opportunity relating to age, disability, gender, gender identity, ethnicity, religion and belief, sexual orientation or socio-economic status?

In answering this question, please include details of:

• Which particular parts of the guidance you think affect equality of opportunity?
• Why and how you think equality of opportunity is affected?

An embargoed version of the final Addendum will be available to stakeholder organisations that comment during this consultation. Stakeholders must respond to the consultation in order to receive a confidentiality form to sign. The response needn’t be formal comments, an email to say ‘no comment’ will suffice. Respondents will receive a confidentiality form after the consultation closes.

The embargoed version will be released two weeks before the official publication and will be subject to the signing of the confidentiality form. If you wish to receive a copy of the embargoed version, please pass the attached form to the person who wishes to be responsible for the embargoed version. This person should then sign the form by hand, include their contact email address and return it to me either by post or scanned and by email by 16 June 2014 .

How to submit your comments:

Responses to the draft Addendum document must be submitted using the comments proforma  (Word version only, PDFs not accepted) ensuring all relevant fields are completed.

Completed comment proformas must be returned to ABCSCupdate@nice.org.uk by 5pm on 9^th April 2014 at the very latest in order to be considered.

The Institute is unable to accept

• Comments from non-registered organisations / individuals – if you wish your comments to be considered please register your organisation as a stakeholder via the NICE website or contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them
• Comments received after the consultation deadline (5pm)
• Comments that are not on the correct proforma
• Comments on the original guideline
• More than one response per stakeholder organisation
• Confidential information or other material that you would not wish to be made public
• Personal medical information about yourself or another person from which your or the person’s identity could be ascertained

What will happen to your comments

• All eligible comments  will be sent to the developers at the end of the consultation
• Comments from registered stakeholders and nominated expert reviewers ONLY will be formally responded to by the developers and posted on the NICE website at the time of the pre-publication check
• No action will be taken upon receipt of personal, individual comments, comments from non-registered organisations and late comments
• PLEASE NOTE: The Institute reserves the right to summarise and edit comments received during consultations, or not to publish them at all, where in the reasonable opinion of the Institute, the comments are voluminous, publication would be unlawful or publication would be otherwise inappropriate.

Comments received in the course of consultations carried out by the Institute are published in the interests of openness and transparency, and to promote understanding of how recommendations are developed. The comments are published as a record of the submissions that the Institute has received, and are not endorsed by the Institute, its officers or advisory committees.

Anticipated addendum publication date: 01 July 2014

See here for more information on NICE’s guideline development process.